https://www.selleckchem.com/pr....oducts/bgj398-nvp-bg
05). Dietary L. acidophilus supplementation consistently showed higher BW, ADG, ADFI, and jejunum and ileum VC ratio at 14 d and 21 d in the presence and absence of E. coli challenge (P less then 0.05). L. acidophilus supplementation reduced the mortality rate caused by E. coli challenge (P less then 0.05), decreased the serum CRP, DAO, and LPS levels at 14 d and 21 d; upregulated the mRNA expression of occludin and ZO-1 in the jejunum and ileum, and downregulated the mRNA expression of iNOS, IL-8, and IL-1β in the jejunum in